Neuroprotection in multiple sclerosis

Clinical Neurology and Neurosurgery

Volumn 108, Issue 3, 2006, Pages 250-254

  Karussis, Dimitrios ^a   Grigoriadis, Savas ^a,b   Polyzoidou, Eleni ^b   Grigoriadis, Nikolaos ^b   Slavin, Shimon ^b   Abramsky, Oded ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Bone marrow mesenchymal stromal cells; Multiple sclerosis; Neuroprotection; Stem cells

Indexed keywords

BETA INTERFERON; GLATIRAMER;

CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CONFERENCE PAPER; DEMYELINATION; DISEASE COURSE; DRUG EFFECT; GLIA CELL; HUMAN; IMMUNOMODULATION; MESENCHYME CELL; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; REMYELINIZATION; STEM CELL TRANSPLANTATION;

HUMANS; IMMUNOLOGIC FACTORS; MULTIPLE SCLEROSIS; NEUROPROTECTIVE AGENTS; STEM CELL TRANSPLANTATION;

EID: 33644629328     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2005.11.007     Document Type: Conference Paper

References (69)

1. C. Lubetzki, A. Williams, and B. Stankoff Promoting repair in multiple sclerosis: problems and prospects Curr Opin Neurol 18 2005 237 244
2. B. Trapp, R. Ransohoff, and R. Rudick Axonal pathology in multiple sclerosis: relationship to neurologic disability Curr Opin Neurol 12 1999 295 302
3. G. Lovas, N. Szilagyi, and K. Majtenyi Axonal changes in chronic demyelinated cervical spinal cord plaques Brain 123 2000 308 317
4. N. Grigoriadis, T. Ben-Hur, and D. Karussis Axonal damage in multiple sclerosis: a complex issue in a complex disease Clin Neurol Neurosurg 106 2004 211 217
5. L. Steinman Multiple sclerosis: a two-stage disease Nat Immunol 2 2001 762 764
6. T. Owens The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage Curr Opin Neurol 16 2003 259 265
7. P. Felts, A. Woolston, and H. Fernando Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide Brain 128 2005 1649 1666
8. A. Bitsch, J. Schuchardt, and S. Bunkowski Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation Brain 123 2000 1174 1183
9. C. Bjartmar, and B. Trapp Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences Curr Opin Neurol 14 2001 271 278
10. M. Buntinx, P. Stinissen, and P. Steels Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions Crit Rev Immunol 22 2002 391 424
11. R. Hohlfeld, M. Kerschensteiner, and C. Stadelmann The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis J Neuroimmunol 107 2000 161 166
12. P. Villoslada, and C. Genain Role of nerve growth factor and other trophic factors in brain inflammation Prog Brain Res 146 2004 403 414
13. J. Gehrmann, R. Banati, and M. Cuzner Amyloid precursor protein (APP) expression in multiple sclerosis lesions Glia 15 1995 141 151
14. N. De Stefano, S. Narayanan, and M. Mortilla Imaging axonal damage in multiple sclerosis by means of MR spectroscopy Neurol Sci 21 2000 S883 S887
15. N. De Stefano, P. Matthews, and L. Fu Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study Brain 121 1998 1469 1477
16. J. Sastre-Garriga, G. Ingle, and D. Chard Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis Arch Neurol 62 2005 569 573
17. J. Ruiz-Pena, P. Pinero, and G. Sellers Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy BMC Neurol 4 2004 8
18. B. Trapp, J. Peterson, and R. Ransohoff Axonal transection in the lesions of multiple sclerosis N Engl J Med 338 1998 278 285
19. Y. Gilgun-Sherki, E. Melamed, and D. Offen The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy J Neurol 251 2004 261 268
20. H. Andrews, P. Nichols, and D. Bates Mitochondrial dysfunction plays a key role in progressive axonal loss in multiple sclerosis Med Hypotheses 64 2005 669 677
21. N. Evangelou, M. Esiri, and S. Smith Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis Ann Neurol 47 2000 391 395
22. P. Stys General mechanisms of axonal damage and its prevention J Neurol Sci 233 2005 3 13
23. C. Rosin, T. Bates, and S. Skaper Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor-dependent and -independent mechanisms J Neurochem 90 2004 1173 1185
24. P. Sarchielli, L. Greco, and A. Floridi Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid Arch Neurol 60 2003 1082 1088
25. D. Pitt, P. Werner, and C. Raine Glutamate excitotoxicity in a model of multiple sclerosis Nat Med 6 2000 67 70
26. L. Steinman Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis J Exp Med 194 2001 F27 F30
27. C. Skulina, S. Schmidt, and K. Dornmair Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood Proc Natl Acad Sci USA 101 2004 2428 2433
28. A. Bitsch, T. Kuhlmann, and C. Da Costa Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology Glia 29 2000 366 375
29. T. Andrews, P. Zhang, and N. Bhat TNFalpha potentiates IFNgamma-induced cell death in oligodendrocyte progenitors J Neurosci Res 54 1998 574 583
30. A. Boullerne, L. Nedelkoska, and J. Benjamins Role of calcium in nitric oxide-induced cytotoxicity: EGTA protects mouse oligodendrocytes J Neurosci Res 63 2001 124 135
31. O. Vladimirova, J. O'Connor, and A. Cahill Oxidative damage to DNA in plaques of MS brains Mult Scler 4 1998 413 418
32. F. Facchinetti, V. Dawson, and T. Dawson Free radicals as mediators of neuronal injury Cell Mol Neurobiol 18 1998 667 682
33. P. Butcher Calcium intake and the protein composition of mouse brain: relevance to multiple sclerosis Med Hypotheses 39 1992 275 280
34. M. Peterlik, and H. Cross Vitamin D and calcium deficits predispose for multiple chronic diseases Eur J Clin Invest 35 2005 290 304
35. M. Kurnellas, A. Nicot, and G. Shull Plasma membrane calcium ATPase deficiency causes neuronal pathology in the spinal cord: a potential mechanism for neurodegeneration in multiple sclerosis and spinal cord injury FASEB J 19 2005 298 300
36. E. Brand-Schieber, and P. Werner Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis Exp Neurol 189 2004 5 9
37. D. Shields, W. Tyor, and G. Deibler Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis Proc Natl Acad Sci USA 95 1998 5768 5772
38. S. Hisahara, H. Okano, and M. Miura Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination Neurosci Res 46 2003 387 397
39. B. Trembly Clinical potential for the use of neuroprotective agents. A brief overview Ann N Y Acad Sci 765 1995 1 20 [discussion 26-7]
40. T. Smith, A. Groom, and B. Zhu Autoimmune encephalomyelitis ameliorated by AMPA antagonists Nat Med 6 2000 62 66
41. Y. Okuda, S. Sakoda, and H. Fujimura Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis J Neuroimmunol 73 1997 107 116
42. P. Ye, and A. D'Ercole Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury Endocrinology 140 1999 3063 3072
43. J. Hong, S. Ryu, and H. Kim Neuroprotective effect of green tea extract in experimental ischemia-reperfusion brain injury Brain Res Bull 53 2000 743 749
44. H. Zhuang, Y.S. Kim, and K. Namiranian Prostaglandins of J series control heme oxygenase expression: potential significance in modulating neuroinflammation Ann N Y Acad Sci 993 2003 208 216 [discussion 287-8]
45. Y. Gilgun-Sherki, H. Panet, and E. Melamed Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis Brain Res 989 2003 196 204
46. H. Salzberg-Brenhouse, E. Chen, and D. Emerich Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration J Pharmacol Exp Ther 306 2003 218 228
47. C. Cid, J. Alvarez-Cermeno, and I. Regidor Caspase inhibitors protect against neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients J Neuroimmunol 136 2003 119 124
48. H. Deluca, and M. Cantorna Vitamin D: its role and uses in immunology FASEB J 15 2001 2579 2585
49. S. Waxman Sodium channels as molecular targets in multiple sclerosis J Rehabil Res Dev 39 2002 233 242
50. H. Webster Growth factors and myelin regeneration in multiple sclerosis Mult Scler 3 1997 113 120
51. R. Linker, M. Maurer, and S. Gaupp CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation Nat Med 8 2002 620 624
52. X. Ni, E. Geller, and M. Eppihimer Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model Mult Scler 10 2004 158 164
53. J. Croxford Therapeutic potential of cannabinoids in CNS disease CNS Drugs 17 2003 179 202
54. A. Lo, C. Saab, and J. Black Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo J Neurophysiol 90 2003 3566 3571
55. T. Boutros, E. Croze, and V. Yong Interferon-beta is a potent promoter of nerve growth factor production by astrocytes J Neurochem 69 1997 939 946
56. K. Biernacki, J. Antel, and M. Blain Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis Arch Neurol 62 2005 563 568
57. O. Malik, A. Compston, and J. Scolding Interferon-beta inhibits mitogen induced astrocyte proliferation in vitro J Neuroimmunol 86 1998 155 162
58. R. Aharoni, B. Kayhan, and R. Eilam Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ Proc Natl Acad Sci USA 100 2003 14157 14162
59. T. Ziemssen, T. Kumpfel, and H. Schneider Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: implications for multiple sclerosis therapy J Neurol Sci 233 2005 109 112
60. J. Kipnis, T. Mizrahi, and E. Hauben Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system Proc Natl Acad Sci USA 99 2002 15620 15625
61. M. Schwartz, and J. Kipnis Autoimmunity on alert: naturally occurring regulatory CD4(+)CD25(+) T cells as part of the evolutionary compromise between a 'need' and a 'risk' Trends Immunol 23 2002 530 534
62. O. Einstein, D. Karussis, and N. Grigoriadis Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis Mol Cell Neurosci 24 2003 1074 1082
63. S. Pluchino, A. Quattrini, and E. Brambilla Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis Nature 422 2003 688 694
64. T. Ben-Hur, O. Einstein, and R. Mizrachi-Kol Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis Glia 41 2003 73 80
65. D. Prockop Marrow stromal cells as stem cells for nonhematopoietic tissues Science 276 1997 71 74
66. D. Bonnet Biology of human bone marrow stem cells Clin Exp Med 3 2003 140 149
67. J. Zhang, Y. Li, and J. Chen Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice Exp Neurol 195 2005 16 26
68. E. Zappia, S. Casazza, and E. Pedemonte Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy Blood 106 2005 1755 1761
69. J. Kanwar, R. Kanwar, and G. Krissansen Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis Brain 127 2004 1313 1331